Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Nurix Therapeutics, Inc. NRIX

Set alert

Price alert · NRIX

All alert types
26.10 USD +0.40 +1.56%

As of Nov 3, 10:12 AM ET

Bid
26.10 × 1
Ask
26.15 × 1
25.70 Day range 26.52
11.67 52-week range 28.23
YTD
+37.59%
1 year
+106.81%
Open
25.72
Prev close
25.70
Mkt cap
2.84B
Vol
258.48K
Avg vol
1.74M
EPS
2.43
P/E
10.72
Div yield
0.00%
More statistics
Low
25.70
High
26.52
Forward P/E
-20.15
Beta
1.78
Short ratio
10.30
Inst. own
111.03%
Dividend
0.00
Ex-div date
Earnings
Jan 27, 2027
50-d avg
24.98
200-d avg
20.18
1y target
34.50

5m chart

Chart tools
Interval
1m5m15m30m

Built from the cached five-day intraday bars.

Signals (101)
NameTimeAgo
SMA: BullishNov 3, 9:30 AM42 minutes ago
SMA: BearishNov 2, 3:55 PM18 hours ago
SMA: BullishNov 2, 3:50 PM18 hours ago
MACD: Buy SignalNov 2, 3:50 PM18 hours ago
SMA: BullishNov 2, 3:45 PM18 hours ago
MACD: Sell SignalNov 2, 3:40 PM18 hours ago
SMA: BearishNov 2, 3:30 PM18 hours ago
SMA: BullishNov 2, 2:55 PM19 hours ago
SMA: BullishNov 2, 2:55 PM19 hours ago
MACD: Buy SignalNov 2, 2:55 PM19 hours ago
MACD: Sell SignalNov 2, 2:45 PM19 hours ago
MACD: Buy SignalNov 2, 2:40 PM19 hours ago
MACD: Sell SignalNov 2, 2:35 PM19 hours ago
SMA: BearishNov 2, 2:20 PM19 hours ago
SMA: BullishNov 2, 2:05 PM20 hours ago
MACD: Buy SignalNov 2, 2:05 PM20 hours ago
MACD: Sell SignalNov 2, 1:25 PM20 hours ago
SMA: BearishNov 2, 1:15 PM20 hours ago
SMA: BullishNov 2, 12:55 PM21 hours ago
SMA: BullishNov 2, 12:55 PM21 hours ago

Newest 20 of 101.

Analyst view

Consensus: none

Price target (mean) 34.50 +32.2% upside
Target (low)
25.00
Target (mean)
34.50
Target (high)
45.00
Ratings (0m) 14 13 buy · 1 hold · 0 sell
  • Strong buy5
  • Buy8
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 14
  • 1 month ago 14
  • 2 months ago 15

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

NRIX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter1.51-0.64 – 5.26-0.82+283.9%287.86M+2020.2%3
Next quarter-0.59-0.59 – -0.59-0.79+25.3%15.00M+139.9%1
Current year3.022.96 – 3.10-3.05+199.0%744.85M+786.9%3
Next year-1.28-2.48 – -0.623.02-142.2%123.22M-83.5%3

Upgrades and downgrades

The latest rating changes

NRIX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 16, 2026HC Wainwright & Co.MaintainedBuyBuy
Oct 13, 2026RBC CapitalMaintainedOutperformOutperform
Oct 13, 2026OppenheimerMaintainedOutperformOutperform
Oct 13, 2026Truist SecuritiesMaintainedBuyBuy
Oct 13, 2026BairdMaintainedOutperformOutperform
Oct 13, 2026NeedhamReiteratedBuyBuy
Aug 10, 2026RBC CapitalMaintainedOutperformOutperform
Aug 4, 2026NeedhamReiteratedBuyBuy
Jul 28, 2026Morgan StanleyMaintainedOverweightOverweight
Jul 22, 2026UBSMaintainedBuyBuy
Jul 13, 2026MizuhoMaintainedOutperformOutperform
Jul 10, 2026Truist SecuritiesMaintainedBuyBuy
Jul 10, 2026RBC CapitalMaintainedOutperformOutperform
Jul 10, 2026StifelMaintainedBuyBuy
Jul 10, 2026BTIGReiteratedBuyBuy
Jul 10, 2026NeedhamReiteratedBuyBuy
Jul 10, 2026HC Wainwright & Co.MaintainedBuyBuy
Jun 18, 2026BairdMaintainedOutperformOutperform
Jun 15, 2026NeedhamReiteratedBuyBuy
Jun 10, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jun 9, 2026Truist SecuritiesMaintainedBuyBuy
Jun 9, 2026BTIGMaintainedBuyBuy
Jun 8, 2026JefferiesMaintainedBuyBuy
Jun 8, 2026Wells FargoMaintainedOverweightOverweight
Jun 8, 2026NeedhamMaintainedBuyBuy
May 18, 2026BTIGReiteratedBuyBuy
Apr 27, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 23, 2026NeedhamReiteratedBuyBuy
Apr 10, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 9, 2026Wells FargoMaintainedOverweightOverweight